AHA Asks Congress to Attach 340B Hospital Protections to Must-Pass Spending Bill

The House Appropriations Committee approved the Labor, Health and Human Services, Education and Related Agencies Appropriations Act on July 10.

The American Hospital Association (AHA) yesterday asked U.S. House and Senate party leaders to ensure that a must-pass spending bill next month protects hospitals from losing their 340B eligibility due to changes in patient and payer mix caused by the

Read More »

Three Drug Makers, Including Two with Contract Pharmacy Restrictions, Post 340B Refund Notices

Bristol Myers Squibb, Novo Nordisk, and Ipsen Biopharmaceuticals notified 340B covered entities this week about refunds for charges above 340B ceiling prices.

Three drug manufacturers—including two that have imposed conditions on 340B contract pharmacy—posted public notices this week to 340B covered entities about refunds for charges above 340B ceiling prices.

Bristol Myers Squibb (BMS) and Novo Nordisk’s notices came to light yesterday

Read More »

Democrats Weigh Passing Build Back Better Act—Possibly Including Drug Pricing Reforms—in “Chunks”

New CBO findings on brand drug price increases “drive home the urgent need to pass robust drug pricing reforms," U.S. Senate Finance Committee Chair Ron Wyden (D-Ore.) said this week.

U.S. Senate Finance Committee Chair Ron Wyden (D-Ore.) said this week that new Congressional Budget Office (CBO) findings on brand drug price increases “drive home the urgent need to pass robust drug pricing reforms.”

“The average net price for brand-name

Read More »

Groups and Individual Health Care Providers Grapple with BMS’s New 340B Contract Pharmacy Policy

Individual 340B covered entities are deciding how to respond to the multi-point 340B contract pharmacy policy that Bristol Myers Squibb (BMS) released last Friday.

Groups that represent 340B hospitals yesterday slammed the multi-point 340B contract pharmacy policy that Bristol Myers Squibb (BMS) released last Friday.

Representatives of grantee covered entities, which BMS exempted from its contract pharmacy restrictions involving most of its products, overwhelmingly

Read More »

With Judge in Astra 340B Case About to Get Promotion, What Will Happen to the Highly Anticipated Case?

The U.S. Senate could elevate Leonard Stark, the federal judge who has presided over AstraZeneca’s 340B contract pharmacy lawsuit, to a federal appeals court as soon as the end of this week.

Leonard Stark, the federal judge who presided over AstraZeneca’s 340B contract pharmacy lawsuit from its start last year, is on the verge of being elevated to a higher court, possibly by the end of this week. If that happens before

Read More »

With Public Health Emergency Extended, 340B Flexibilities to Continue

340B program flexibilities will continue for another 90 days under the latest extension of the COVID-19 national public health emergency.

340B program flexibilities will continue under the eighth 90-day extension of the COVID-19 national public health emergency (PHE) late last week.

U.S. Health and Human Services (HHS) Secretary Xavier Becerra renewed the PHE on Friday, Jan. 14.

In

Read More »

Breaking News

BMS Clamps Down on 340B Contract Pharmacy for Most of its Drugs but Expands 340B Access to its Controversial Myeloma Meds Program

BMS yesterday imposed restrictions on 340B pricing on most of its covered outpatient drugs, while liberalizing its policy on access to 340B pricing on its expensive cancer drugs Revlimid, Pomalyst, and Thalomid.

Bristol Myers Squibb (BMS) yesterday became the 12th drug manufacturer to impose restrictions on 340B pricing when hospitals and grantee covered entities contract with pharmacies to dispense drugs to patients.

According to late-day email messages from BMS to 340B

Read More »

News Alert: NACHC Long-Time Leader Van Coverden Takes Leave, Could Augur Generational Change

NACHC informed health center stakeholders last night that its long-time leader Tom Van Coverden (left) has taken leave. NACHC Senior Vice President for Western Operations Rachel Gonzalez-Hanson has been appointed NACHC's interim president and CEO.

The National Association of Community Health Centers said in an email to its contacts yesterday that Tom Van Coverden, 74, hired by NACHC in 1975 and its leader for decades, has taken leave and been replaced by an interim president

Read More »

340B-Related Conference Organizers Readjust as COVID-19 Persists

The Marriott Marquis San Diego is the venue for both the 340B Coalition 2022 winter conference and the preceding 340B University educational program.

The 340B Coalition, citing the ongoing COVID-19 pandemic, decided Tuesday to give registrants for its upcoming Jan. 31 to Feb. 2 winter conference in San Diego, Calif., the option of attending in person or remotely via an online portal.

Apexus,

Read More »

340B “Anti-Pickpocketing” Bills Filed in Five States

The Florida Senate and four other state legislative chambers are considering bills 340B "anti-pickpocketing" legislation.

Bills have been filed in at least five state legislatures to protect 340B covered entities and their contract pharmacies from discrimination by pharmacy benefit managers (PBMs).

Sixteen states have enacted one or more such laws since 2019, according to

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live